imatinib mesylate has been researched along with Thoracic Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, S; Dimitrakopoulou-Strauss, A; Gruenwald, V; Haller, F; Hohenberger, P; Kasper, B; Limprecht, R; Pilz, L; Rauch, G; Reichardt, P; Sommer, M | 1 |
Cheng, JW; Hou, YY; Lu, SH; Tan, YS; Wang, H; Xu, ST; Zheng, RH | 1 |
De Pennington, N; Fearnhead, N; Maynard, ND; Sujendran, V; Warren, BF | 1 |
1 trial(s) available for imatinib mesylate and Thoracic Neoplasms
Article | Year |
---|---|
Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG).
Topics: Abdominal Neoplasms; Abdominal Wall; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease Progression; Disease-Free Survival; Extremities; Female; Fibromatosis, Aggressive; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Pyrimidines; Response Evaluation Criteria in Solid Tumors; Retroperitoneal Neoplasms; Soft Tissue Neoplasms; Thoracic Neoplasms; Thoracic Wall; Treatment Outcome; Young Adult | 2017 |
2 other study(ies) available for imatinib mesylate and Thoracic Neoplasms
Article | Year |
---|---|
Primary thoracic cavity gastrointestinal stromal tumor.
Topics: Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; DNA Mutational Analysis; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Reoperation; Thoracic Neoplasms; Thoracotomy; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Proposals for the management of gastrointestinal stromal tumours of the stomach.
Topics: Adult; Aged; Aged, 80 and over; Antigens, CD34; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Disease-Free Survival; Female; Follow-Up Studies; Gastrectomy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatectomy; Piperazines; Population Surveillance; Proto-Oncogene Mas; Proto-Oncogene Proteins c-kit; Pyrimidines; Splenectomy; Stomach Neoplasms; Thoracic Neoplasms; Thoracic Wall; Treatment Outcome | 2007 |